Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Philip Kim / MiNK Therapeutics

Philip Kim & MiNK Therapeutics

1 shared events · Importance 3 · Last updated May 05, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
36.666666666666664
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (1)
39
Business
Soleno Therapeutics DCCR Securities Lawsuits
Philip Kim: Philip Kim, an attorney at Rosen Law Firm, is encouraging investors to contact him for information on the class action lawsuit against MiNK Therapeutics.
MiNK Therapeutics: MiNK Therapeutics is the primary defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about the safety and commercial viability of its drug candidate, DCCR. The company's stock price has significantly declined following reports of safety concerns, a patient death, and disruptions in DCCR's launch.
Apr 01, 2026 · 83 articles
NEWSDESK
Explore this relationship live

Track how Philip Kim and MiNK Therapeutics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.